<DOC>
	<DOCNO>NCT00928031</DOCNO>
	<brief_summary>The objective study collect disease status overall survival information Subjects MDX-010 study .</brief_summary>
	<brief_title>Long-term Data Collection Subjects MDX-010 Studies</brief_title>
	<detailed_description>This multicenter , follow-up study 191 subject metastatic melanoma previously enrol treated ipilimumab study MDX010-02 , MDX010-08 , MDX010-15 . The purpose study 1 ) collect date cause death , know , deceased subject participate specified study ; 2 ) collect date progression subject complete study stable disease well ; 3 ) prospectively follow survive subject determine progression-free overall survival .</detailed_description>
	<mesh_term>Melanoma</mesh_term>
	<criteria>1 . Subjects previously enrol MDX010 study MDX01002 , MDX01008 , MDX01015 . 2 . Subjects ( applicable , next kin ) , alive time contact must read , understood , provide write informed consent health Insurance Portability Accountability Act ( HIPAA ) authorization nature study fully explain . 3 . For subject die lose followup ( subject status end original ipilimumab study ) , approval appropriate site IRB , specify limit appropriate mean obtain information , must grant prior collection information .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2010</verification_date>
</DOC>